|
Profile
|
Delegates :
Tomohiro Takano |
|
Incorporated :
January 1 , 2017 |
Paid in Capital :
Million yen |
Employees :
5 人 |
Address :
2-11-3, Meguro, Meguro-ku, Tokyo, Japan TOKYO
〒1530063
|
TEL/FAX :
050 5539 3129 / |
URL:
http://www.awakens.co |
Attachment :
PitchDeck_storyboard.pdf [ 713.6KiB ] |
Mission/Background :
AWAKENS is a genomic startup building GENOME LINK, a "Personal DNA Cloud" to connect users and DNA-personalized apps. Our mission is to unleash the benefit of owning DNA data by 1. building an infrastructure of consumer genomics and 2. catalyze the DNA-personalization movement with value-adding creators and companies. |
Technology & Business
|
Full access to whole genome data and reliable information on how to interpret the data is AWAKENS’ top value proposition. Most genetic testing services today read only 0.03% of the genome. GENOMIC LINK reads and visualizes 100%. AWAKENS strives to visualize what existing genetic testing services have abstracted in their genetic reports. You can browse through a comprehensive visual representation of your genome and learn about 100+ traits: this tool connects your genome data to an in-house annotation database, which tells you how specific regions of the genome can be understood. Traits include personality, intelligence, and nutrition. The only information serving the purpose of science education is released in the U.S for now. Information on medical traits, such as the risk for a certain disease, will be provided in the future as partnerships with healthcare institutions and healthcare companies are established.
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
GENOME LINK
|
Service/Marketing
|
Personal DNA Cloud
|
500,000 users in the U.S.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
The company starts from Illumina's incubation office in San Francisco in 2017 and now joins SkyDeck at UC Berkley in 2018.
|
Alliance strategy
|
- Sales partner of GENOME LINK for consumers in the U.S., Japan and other countries - Client partner for the collaborative development of DNA-personalized products in the U.S. and Japan in the field of medical, fitness, food, nutrition, and research.
|
|
|